The effects of targeted therapy for gastric cancer patients are as follows: 1. The percentage of gastric cancer patients who exhibit HER2-positive is relatively low, and only 10% of them can obtain certain efficacy with Herceptin. Meanwhile, due to the inhibitory nature of gastric cancer and the fact that HER2-positive patients can also have HER2-negative cells in their bodies, there is no reliable and effective targeted therapy drug for gastric cancer at present; 2. Targeted therapy for gastric cancer blood vessels is one of the effective methods of adjuvant therapy for gastric cancer, such as Apatinib and foreign low molecular targeting drugs and monoclonal antibody drugs. Specific medication should be combined with clinic and guided by doctor’s consultation.